CVS Health (CVS) Stock Price Target Raised on Margin Recovery
Published on 5/11/2026
AI Summary
Mizuho has increased the stock price target for CVS Health (CVS) due to anticipated margin recovery. This revision signifies confidence in the company's ability to improve profitability, which could have a positive effect on its share price. The adjustment reflects ongoing market assessments regarding CVS's performance and operational efficiency. Analysts' price targets are significant indicators of expected market movements and investor sentiment.
Related News
Earnings
Savara (SVRA) CFO Executes 580,187 Options, Sells 394,528 Shares
Jun 27
Markets
Medtronic (MDT) Tariff Impact Reduces Estimates to $250 Million
Jun 27
Earnings
Bruker Corporation (BRKR) Price Target Raised to $65 by JPMorgan
Jun 27
Earnings
BJ's Restaurants (BJRI) Insider Sells $405,000 in Shares
Jun 27